Literature DB >> 29128104

Effects of intermedin on autophagy in cerebral ischemia/reperfusion injury.

Meng Wang1, Jing Wang2, Zhengang Liu3, Xin Guo1, Ning Wang4, Nana Jia4, Yanshu Zhang5, Jie Yuan6.   

Abstract

OBJECTIVE: This study aimed to evaluate the effects of intermedin (IMD) on autophagy in cerebral ischemia/reperfusion (I/R) injury (CIRI).
METHODS: Sixty rats were randomly averaged into four groups: sham, ischemia/reperfusion (I/R), IMD, and 3-methyladenine (3-MA). In the sham group, the right common carotid artery, external carotid artery, and internal carotid artery were detached, and no monofilament was inserted. In the other groups, two hours after cerebral ischemia, the rats were injected through the lateral ventricle with normal saline for I/R group, IMD for the IMD group, and 3-MA for the 3-MA group for 24h. The cerebral injury was assessed by evaluation of neurological function, hematoxylin and eosin (H&E) staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The expressions of autophagy associated proteins, such as microtubule-associated protein 1 light chain 3 (LC3), Beclin1, and sequestosome 1 (P62) were analyzed using immunohistochemistry staining and western blot. Meanwhile, transmission electron microscopy was used to investigate the ultrastructure of the brains.
RESULTS: IMD could reduce neuron cell damage and infarction formation and has a protective effect against CIRI as 3-MA. The levels of LC3II/LC3I and Beclin1 were significantly decreased and the P62 level was significantly higher in the IMD group compared with I/R group, which is similar to the effect of 3-MA on CIRI.
CONCLUSIONS: IMD has a similar effect as 3-MA, can reduce pathological neuronal injury and protect the brain against CIRI in rats by attenuating the effects of autophagy. Our findings provide evidence for IMD's protective effects in relation to ischemic cerebrovascular diseases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-methyladenine (3-MA); Autophagy; Beclin1; Cerebral ischemia/reperfusion injury (CIRI); Intermedin (IMD); Microtubule-associated protein 1 light chain 3 (LC3)

Mesh:

Substances:

Year:  2017        PMID: 29128104     DOI: 10.1016/j.npep.2017.10.004

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

Review 1.  The role of autophagy in acute brain injury: A state of flux?

Authors:  Michael S Wolf; Hülya Bayır; Patrick M Kochanek; Robert S B Clark
Journal:  Neurobiol Dis       Date:  2018-04-26       Impact factor: 5.996

2.  Neuroprotection of Intermedin Against Cerebral Ischemia/Reperfusion Injury Through Cerebral Microcirculation Improvement and Apoptosis Inhibition.

Authors:  Xin Guo; Jie Yuan; Meixi Li; Meng Wang; Peiyuan Lv
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

3.  Long non-coding RNA NORAD protects against cerebral ischemia/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p/YWHAG.

Authors:  Xinyu Zhou; Zhonglong Wang; Bingchao Xu; Niu Ji; Pin Meng; Lei Gu; Ying Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.